Treatment Monitoring in Osteoporosis & its Importance

Treatment Monitoring in Osteoporosis & its Importance

We know by now that we need to eat the right foods, need to work out, and do stuff that is healthy for us. Because maintaining good health does not happen by accident, it requires work and smart lifestyle choices. But sometimes when we wake up at 6 am to hit the gym before work or shunning the donuts in breakfast, it’s easy to lose sight of for what are we doing all these. So here are some top articles choices that can keep you motivated to lead a healthy lifestyle and keep diseases at bay.

Treatment Monitoring in Osteoporosis & its Importance

Osteoporosis is a chronic medical problem and need long term treatment like any other chronic health problems. Monitoring the treatment to find out the response to the treatment or preventive measures is an important aspect and part of treatment, to find out if the treatment offered to the patient is adequate or not. Monitoring of treatment of osteoporosis is vital, as it can make difference between a successful treatment and failure of treatment and its consequences such as increased risk of fractures. It is important to find out the treatment offered to a patient of osteoporosis is doing its job satisfactorily or not and for that we need to monitor the treatment of osteoporosis.

But unfortunately, at present there is no clear-cut and well-accepted guideline for monitoring the treatment of osteoporosis. The main aim of treatment of osteoporosis is to increase bone mass as much as practicable (although most of the treatment regimens produce only small to moderate increase in bone mass, with only few exceptions) and measurement of BMD (Bone Mass Density) can be used as a tool to monitor the treatment of osteoporosis.

If BMD is used as a tool to monitor treatment of osteoporosis, a positive change of approximately 4% or more in the spine and 6% or more in the hip can be considered significant in any individual. Hip is preferred over spine due to larger surface area and greater reproducibility.

One disadvantage of using BMD to monitor treatment of osteoporosis is the time it take to produce significant positive changes in bone mass increase, which may take several years and if it ever take place. That is the reason if monitoring is to be done, it should be done at least 2 years after initiating treatment and repeated every two years. The change of treatment modality should only be done in case of reduction (significant reduction) in BMD.

Biochemical markers of bone turnover may also be used to monitor treatment of osteoporosis, but used less frequently due to difficulty in technique and accuracy.

Avatar for admin

Related Posts

1 Comment

  • Latest Osteoporosis Premenopausal Women Auctions | Menopause-Vaginal Diary
    December 10, 2010 - 12:45 pm

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.